U.S. FDA Grants Fast Track Designation to Novavax’ H7N9 Influenza Virus-Like Particle Vaccine Candidate Adjuvanted With Matrix-M(TM) Nasdaq:NVAX

October 31, 2014 12:20 pm

https://globenewswire.com/news-release/2014/10/29/677901/10105274/en/U-S-FDA-Grants-Fast-Track-Designation-to-Novavax-H7N9-Influenza-Virus-Like-Particle-Vaccine-Candidate-Adjuvanted-With-Matrix-M-TM.html

Leave a Reply

Your email address will not be published. Required fields are marked *


*

Get in touch

Give us a call, or drop us an email. We'd love to hear from you!

Get in touch now